Primary prevention of gastrointestinal bleeding due to portal hypertension;Prevention primaire des hemorragies digestives de l'hypertension portale

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 5, 1997, Pages 391-393

  Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE 5 NITRATE; ISOSORBIDE MONONITRATE; NADOLOL; PROPRANOLOL;

ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; PORTAL HYPERTENSION; SHORT SURVEY; REVIEW;

ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS;

EID: 0030627059     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (29)

1. Calès P, Pascal JP. Histoire naturelle des varices œsophagiennes au cours de la cirrhose (de la naissance à la rupture). Gastroenterol Clin Biol 1988;12:245-54.
2. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-9.
3. Kleber G, Sauerbruch T, Ansari H, Paumgartner G. Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology 1991;100:1332-7.
4. Lebrec D. Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding. Pharmacol Ther 1994;61:65-107.
5. Gameel K, Waked I, Saleh S, Sallam M, Abdel-Fattah S. Prophylactic endoscopic variceal band ligation (EVL) versus sclerotherapy (ES) for the prevention of variceal bleeding. An interim report of a prospective randomized controlled trial in schistosomal portal hypertension (abstract). Hepatology 1996;22:251A.
6. Lo GH, Hwu JH, Lai KH. Prophylactic banding ligation of high-risk esophageal varices: an interim report (abstract). Gastroenterology 1995;108:A1112.
7. Sarin SK, Guptan KRC, Jain AK, Sundaram KR. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol 1996;8:337-42.
8. Groszmann RJ, Bendtsen F, Bosch J, Fleig W, Grace ND, Lebrec D, et al. Baveno II consensus statements: drug therapy for portal hypertension. In: De Franchis R, ed. Portal hypertension II. Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science, 1996:98-9.
9. Poynard T, Calès P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 1991;324:1532-8.
10. Hayes PC, Davis JM, Lewis JA, Bouchier IA. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990;336:153-6.
11. Pagliaro L, D'Amico G, Sörensen TIA, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 1992;117:59-70.
12. Calès P, and the Study Group of Primary Prophylaxis. Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. Gastroenterol Clin Biol 1992;16:504-10.
13. Groszinann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
14. McCornick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK. Clinical vs hemodynamics response to drugs in portal hypertension (abstract). Hepatology 1995;22:255A.
15. Angelico M, Carli L, Piat C, Gentile S, Rinaldi V, Bologna E, et al. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology 1993;104:1460-5.
16. Salerno F, Borroni G, Cazzaniga M, Bissoli F, Lorenzano E, Maggi A, et al. Nadolol and isosorbide-5-mononitrate (Is-5-Mn) for preventing bleeding in cirrhotics with ascites (abstract). J Hepatol 1996;24 (Suppl. 1):92.
17. Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P, et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Lancet 1996;348:1677-81.
18. Italian Multicenter Project for Propranolol in Prevention of Bleeding. Propranolol prevents first gastrointestinal bleeding in nonascitic cirrhotic patients: final report of a multicenter randomized trial. J Hepatol 1989;9:75-83.
19. Andréani T, Poupon RE, Balkau B, Trinchet JC, Grangé JD, Peigney N, et al. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology 1991;14:1413-9.
20. Conn HO, Grace ND, Bosch J, Groszmann RJ, Rodes J, Wright SC. Propranolol in the prevention of the first hemorrhage from esophageal varices: results of a randomized double blind cooperative clinical trial. Hepatology 1991;13:902-12.
21. Calès P, Desmorat H, Vinel JP, Caucanas JP, Ravaud A, Gerin P, et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut 1990;31:1298-302.
22. Sarin S, Laoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343-9.
23. Groupe Français de la Prévention Pré-primaire. Etude contrôlée randomisée du propranolol dans la prévention des grosses varices œsophagiennes chez les malades atteints de cirrhose (résumé). Gastroenterol Clin Biol 1996;20:A7.
24. Plevris JN, Elliot R, Mills PR, Hislop WS, Davies JM, Bouchier IAD, et al. Effect of propranolol on prevention of first variceal bleeding and survival in patients with chronic liver disease. Aliment Pharmacol Ther 1994;8:63-70.
25. Kiire CF. Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis. Br Med J 1989;298:1363-5.
26. Qureshi H, Zuberi SJ, Alam E. Efficacy of oral propranolol and injection sclerotherapy in the long-term management of variceal bleeding. Digestion 1990;46:193- 8.
27. Payen JL, Calès P. Modifications gastriques au cours de la cirrhose. Gastroenterol Clin Biol 1991;15:285-95.
28. Burtin P, Calès P, Pilette C, Boyer J. Prévalence, spécificité et interassociation des lésions diffuses de la muqueuse gastrique au cours de la cirrhose (résumé). Gastroenterol Clin Biol 1992;16:A21.
29. Pérez-Ayuso RM, Piqué JM, Bosch J, Panés J, Gonzalez A, Pérez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991;337: 1431-4.